EGF-receptor targeted liposomes with boronated acridine: Growth inhibition of cultured glioma cells after neutron irradiation

References

• Barth R F, Coderre J A, Vicente M G, Blue T E. Boron neutron capture therapy of cancer: Current status and future prospects. Clin Cancer Res 2005; 11: 3987–4002
   PubMed Web of Science ®Google Scholar
• Briesmeister J F. MNCP? – A general Monte Carlo N-particletransport code. Los Alamos National Laboratory, USA 1997, Version 4B, LA-12625-M
   Google Scholar
• Capala J, Sköld K, H-Stenstam B, Munck Af Rosenschöld P, Giusti V, Persson C, Wallin E, Brun A, Carlsson J, Salford L, Ceberg C, Persson B, Pellettieri L, Henriksson R. Clinical BNCT studies in Sweden. Research and development in Neutron Capture Therapy, W Sauerwein, R Moss, A Wittig. Monduzzi Editore S. p. A., Essen 2002; 1101–1106
   Google Scholar
• Capala J, Stenstam B H, Sköld K, Munck Af Rosenschöld P, Giusti V, Persson C, Wallin E, Brun A, Franzen L, Carlsson J, Salford L, Ceberg C, Persson B, Pellettieri L, Henriksson R. Boron neutron capture therapy for glioblastoma multiforme: clinical studies in Sweden. J Neurooncol 2003; 62: 135–144
   PubMed Web of Science ®Google Scholar
• Carlsson J, Gedda L, Gronvik C, Hartman T, Lindstrom A, Lindstrom P, Lundqvist H, Lovqvist A, Malmqvist J, Olsson P, Essand M, Ponten J, Sjoberg S, Westermark B. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor. Int J Radiat Oncol Biol Phys 1994; 30: 105–115
   PubMed Web of Science ®Google Scholar
• Carlsson J, Kullberg E B, Capala J, Sjoberg S, Edwards K, Gedda L. Ligand liposomes and boron neutron capture therapy. J Neurooncol 2003; 62: 47–59
   PubMed Web of Science ®Google Scholar
• Chaffanet M, Chauvin C, Laine M, Berger F, Chedin M, Rost N, Nissou M F, Benabid A L. EGF receptor amplification and expression in human brain tumours. Eur J Cancer 1992; 28: 11–17
   PubMedGoogle Scholar
• Collins V P. Amplified genes in human gliomas. Sem Cancer Biol 1993; 4: 27–32
   PubMed Web of Science ®Google Scholar
• Feakes D A, Shelly K, Hawthorne M F. Selective boron delivery to murine tumors by lipophilic species incorporated in the membranes of unilamellar liposomes. Proc Natl Acad Sci USA 1995; 92: 1367–1370
   PubMed Web of Science ®Google Scholar
• Forssen E A, Coulter D M, Proffitt R T. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res 1992; 52: 3255–3261
   PubMed Web of Science ®Google Scholar
• Ghaneolhosseini H, Tjarks W, Sjöberg S. Synthesis of novel Boronated Acridines- and Spermidines as possible agents for BNCT. Tetrahedron 1998; 54: 3877–3884
   Web of Science ®Google Scholar
• Giusti V, Munck Af Rosenschöld P, Sköld K, Montagnini B, Kierkegaard J, Capala J. Monte Carlo description and validation of the Studsvik BNCT Clinical Beam. Research and development in Neutron Capture Therapy, W Sauerwein, R Moss, A Wittig. Monduzzi Editore S. p. A., Essen 2002; 145–151
   Google Scholar
• Hartman T, Carlsson J. Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapy. Radiother Oncol 1994; 31: 61–75
   PubMed Web of Science ®Google Scholar
• Hawthorne M F, Shelly K. Liposomes as drug delivery vehicles for boron agents. J Neurooncol 1997; 33: 53–58
   PubMed Web of Science ®Google Scholar
• Johnsson M, Bergstrand N, Edwards K. Optimization of drug loading procedures and characterization of liposomal formulations of two novel agents intended for boron neutron capture therapy (BNCT). J Liposome Res 1999; 9: 53–79
   Web of Science ®Google Scholar
• Kullberg E, Bergstrand N, Carlsson J, Edwards K, Johnsson M, Sjoberg S, Gedda L. Development of EGF-conjugated liposomes for targeted delivery of boronated DNA-binding agents. Bioconjugate Chem 2002; 13: 737–743
   PubMed Web of Science ®Google Scholar
• Kullberg E, Nestor M, Gedda L. Tumor-cell targeted epidermal growth factor liposomes loaded with boronated acridine: Uptake and processing. Pharmaceut Res 2003; 20: 229–236
   PubMed Web of Science ®Google Scholar
• Laverman P, Boerman O C, Oyen W J, Dams E T, Storm G, Corstens F H. Liposomes for scintigraphic detection of infection and inflammation. Advanced Drug Deliv Rev 1999; 37: 225–235
   PubMed Web of Science ®Google Scholar
• Lindström P, Olsson P, Malmqvist J, Pettersson J, Lemmen P, Werner B, Sjöberg S, Olin A, Carlsson J. New carborane-based compounds for boron neutron capture therapy: Binding and toxicity of ANC-1, DAC-1 and B-Et-11-OMe in cultured human glioma and mouse melanoma cells. Anticancer Drugs 1994; 5: 43–52
   PubMed Web of Science ®Google Scholar
• Maruyama K, Yuda T, Okamoto A, Kojima S, Suginaka A, Iwatsuru M. Prolonged circulation time in vivo of large unilamelar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol). Biochim Biophys Acta 1992; 1128: 44–49
   PubMed Web of Science ®Google Scholar
• Mehta S C, Lai J C, Lu D R. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy. J Microencapsul 1996; 13: 269–279
   PubMed Web of Science ®Google Scholar
• Munck Af Rosenschöld P, Giusti V, Capala J, Ceberg C, Sköld K, Andreo P, H-Stenstam B, Salford L, Persson B. Current status of dosimetry at the Boron Neutron Capture Therapy facility at Studsvik, Sweden. Research and development in Neutron Capture Therapy, W Sauerwein, R Moss, A Wittig. Monduzzi Editore S. p. A., Essen 2002; 437–441
   Google Scholar
• Nakanishi A, Guan L, Kane R R, Kasamatsu H, Hawthorne M F. Toward a cancer therapy with boron-rich oligomeric phosphate diesters that target the cell nucleus. Proc Natl Acad Sci USA 1999; 96: 238–241
   PubMed Web of Science ®Google Scholar
• Olsson P, Black M, Capala J, Coderre J, Hartman T, Makar M, Malmquist J, Pettersson J, Tilly N, Sjoberg S, Carlsson J. Uptake, toxicity and radiation effects of the boron compounds DAAC-1 and DAC-1 in cultured human glioma cells. Int J Radiat Biol 1998; 73: 103–112
   PubMed Web of Science ®Google Scholar
• Papahadjopoulos D, Allen T M, Gabizon A, Mayhew E, Matthay K, Huang S K, Lee K D, Woodle M C, Lasic D D, Redemann C. Sterically stabilized liposomes: Improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc Natl Acad Sci USA 1991; 88: 11460–11464
   PubMed Web of Science ®Google Scholar
• Setiawan Y, Moore D E, Allen B J. Selective uptake of boronated low-density lipoprotein in melanoma xenografts achieved by diet supplementation. Br J Cancer 1996; 74: 1705–1708
   PubMed Web of Science ®Google Scholar
• Sharma R P, Edwards I R. cis-Platinum: subcellular distribution and binding to cytosolic ligands. Biochem Pharmacol 1983; 32: 2665–2669
   PubMed Web of Science ®Google Scholar
• Shelly K, Feakes D A, Hawthorne M F, Schmidt P G, Krisch T A, Bauer W F. Model studies directed toward the boron neutron-capture therapy of cancer: Boron delivery to murine tumors with liposomes. Proc Natl Acad Sci USA 1992; 89: 9039–9043
   PubMed Web of Science ®Google Scholar
• Tilly N, Olsson P, Hartman T, Coderre J, Makar M, Malmquist J, Sjoberg S, Pettersson J, Carlsson J, Glimelius B. In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1. Radiother Oncol 1996; 38: 41–50
   PubMed Web of Science ®Google Scholar
• Westermark B, Magnusson A, Heldin C-H. Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells. J Neurosci Res 1982; 8: 491–507
   PubMed Web of Science ®Google Scholar
• Wu G, Barth R F, Yang W, Chatterjee M, Tjarks W, Ciesielski M J, Fenstermaker R A. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjug Chem 2004; 15: 185–194
   PubMed Web of Science ®Google Scholar
• Yanagie H, Kobayashi H, Takeda Y, Yoshizaki I, Nonaka Y, Naka S, Nojiri A, Shinnkawa H, Furuya Y, Niwa H, Ariki K, Yasuhara H, Eriguchi M. Inhibition of growth of human breast cancer cells in culture by neutron capture using liposomes containing 10B. Biomed Pharmacother 2002; 56: 93–99
   PubMed Web of Science ®Google Scholar
• Yanagie H, Tomita T, Kobayashi H, Fujii Y, Nonaka Y, Saegusa Y, Hasumi K, Eriguchi M, Kobayashi T, Ono K. Inhibition of human pancreatic cancer growth in nude mice by boron neutron capture therapy. Br J Cancer 1997; 75: 660–665
   PubMed Web of Science ®Google Scholar
• Yanagie H, Tomita T, Kobayashi H, Fujii Y, Takahashi T, Hasumi K, Nariuchi H, Sekiguchi M. Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br J Cancer 1991; 63: 522–526
   PubMed Web of Science ®Google Scholar